First National Advisers’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,765
Closed -$348K 258
2025
Q4
$348K Sell
2,765
-28,062
-91% -$3.66M 0.05% 197
2025
Q3
$4.51M Buy
30,827
+272
+0.9% +$41.1K 0.61% 39
2025
Q2
$4.77M Buy
30,555
+2,212
+8% +$351K 0.7% 30
2025
Q1
$4.67M Buy
28,343
+58
+0.2% +$9.64K 0.75% 30
2024
Q4
$4.61M Buy
28,285
+1,176
+4% +$210K 0.75% 32
2024
Q3
$5.3M Buy
27,109
+2,877
+12% +$530K 0.84% 25
2024
Q2
$4.2M Buy
24,232
+8,312
+52% +$1.38M 0.77% 30
2024
Q1
$2.68M Buy
15,920
+2,206
+16% +$413K 0.6% 50
2023
Q4
$2.71M Buy
13,714
+4,269
+45% +$756K 0.78% 36
2023
Q3
$1.64M Buy
9,445
+3,951
+72% +$717K 0.73% 43
2023
Q2
$946K Buy
5,494
+61
+1% +$10.5K 0.87% 37
2023
Q1
$904K Buy
5,433
+160
+3% +$26.2K 1.03% 34
2022
Q4
$773K Buy
5,273
+514
+11% +$76.1K 0.99% 34
2022
Q3
$706K Buy
4,759
+1,347
+39% +$225K 1.05% 28
2022
Q2
$587K Buy
+3,412
New +$590K 1.22% 27

Other funds holding ZTS

First National Advisers's ZTS Position: Q1 2026 in Review

First National Advisers sold out of Zoetis (ZTS) in Q1 2026, closing a stake of 2,765 shares — an estimated $348K sold.

First National Advisers first reported a position in ZTS in Q2 2022 and held it in 15 quarters. The position peaked at $5.3M in Q3 2024. 1,614 funds tracked by Wall St. Rank hold ZTS as of Q1 2026.

  • First National Advisers reported no remaining Zoetis position as of Q1 2026 after selling out during the quarter.
  • First National Advisers sold 2,765 Zoetis shares in Q1 2026, an estimated $348K.
  • First National Advisers first reported a position in Zoetis in Q2 2022 and held it in 15 quarters.
  • First National Advisers's Zoetis position peaked at $5.3M in Q3 2024.
  • 1,614 funds tracked by Wall St. Rank held Zoetis as of Q1 2026.

Based on First National Advisers's 13F filing for Q1 2026, filed 8 May 2026.